Editorial: Magnetic Resonance-Guided Focused Ultrasound: Physical Principles and Biomedical Applications

Allegra Conti, Hermes A. S. Kamimura, Anthony Novell, Andrea Duggento, Nicola ToschiFrontiers in Physics 2021 · DOI · OpenAlex

Introduction

Magnetic resonance-guided focused ultrasound (MRgFUS) represents a paradigm shift in non-invasive therapy. By integrating the high-resolution imaging and thermal mapping capabilities of Magnetic Resonance Imaging (MRI) with the therapeutic energy of Focused Ultrasound (FUS), clinicians can now target deep-seated tissues with surgical precision. This technology is currently being explored in over 90 clinical trials, offering potential alternatives to traditional surgery for neurological, oncological, and musculoskeletal conditions.

The Challenge of Non-Invasive Precision

Treating the human brain presents a unique set of obstacles. Traditional interventions are often highly invasive, while systemic drug therapies frequently fail to penetrate the Blood-Brain Barrier (BBB). While Focused Ultrasound can deliver mechanical or thermal energy to these regions, the ultrasound beam itself is "blind" and susceptible to distortion by the human skull.

The primary challenge addressed in recent research is ensuring that energy deposition is both accurate and safe. MRI guidance provides the necessary real-time feedback to account for skull-induced distortions and to monitor tissue temperature, ensuring that "organs-at-risk" remain protected while the target lesion is effectively treated.

Methodological Advancements

Recent contributions to the field highlight a spectrum of acoustic intensity regimes tailored to specific clinical needs:

  • High-Intensity Focused Ultrasound (HIFU): This modality is primarily used for thermal ablation. By concentrating acoustic energy, HIFU can create precise lesions, such as those required for unilateral ventral intermediate nucleus (Vim) thalamotomy to treat medically refractory tremors.
  • Low-Intensity Focused Ultrasound (LIFU): LIFU is utilized for non-destructive applications, including neuromodulation (the temporary excitation or inhibition of neural circuits) and the transient opening of the BBB for targeted drug delivery.
  • Hardware and Microbubble Engineering: Innovations include the development of flexible-shape, MR-compatible ultrasonic array probes that conform to patient anatomy. Furthermore, the use of gas-filled microbubbles has become a cornerstone of BBB permeabilization; when exposed to ultrasound, these bubbles oscillate, physically nudging the barrier open to allow the passage of therapeutic agents.

Key Insights and Clinical Results

Research synthesized in this topic reveals several critical findings for the future of the field:

  1. The Role of Skull Density Ratio (SDR): The SDR has been identified as the primary determinant of thermal success in brain treatments. This underscores the necessity for personalized "ultrasound prescriptions" based on individual bone structure.
  2. Quantifiable Neuromodulation: Studies in non-human primates have demonstrated that low-intensity pulses can modulate behavior with a predictable "return-to-baseline" period of 18–31 minutes, confirming the safety and reversibility of the technique.
  3. Microbubble Stability: For drug delivery to be economically viable, the shelf-life of microbubbles is essential. Research has shown that even stored, homemade microbubbles can effectively facilitate BBB opening over several weeks, potentially lowering treatment costs.
  4. Clinical Scalability: The transition from experimental to clinical use is evidenced by the integration of 1024-element ultrasound phased arrays into standard 1.5T and 3T MRI scanners, facilitating treatments for Parkinson’s disease and various cancers.

Future Directions and Limitations

Despite significant progress, hurdles remain. The exact mechanical pathways of neuromodulation—whether driven by membrane deformation or subtle heat deposition—are still under investigation. Additionally, there is a pressing need for automated treatment planning software capable of correcting B-mode image distortions in real-time.

The next frontier for MRgFUS lies in "priming" tissues for advanced biological treatments. By moving beyond simple tissue destruction, ultrasound may soon play a pivotal role in immunotherapy, gene therapy, and cell therapy, marking a new era of multi-modal, non-invasive medicine.

Summary updated

Abstract

Magnetic resonance-guided focused ultrasound (MRgFUS) is a non-invasive technique used in more than ninety clinical trials as an alternative to standard treatments for neurological, oncological and musculoskeletal diseases. Indeed, magnetic resonance (MR)-guidance allows targeted treatments through a wide range of focused ultrasound (FUS) intensities inducing mechanical, thermal, and neuroelectric effects on the tissue while preserving surrounding organs-at-risk. This Research Topic gathered contributions from experts in MRgFUS and summarized recent and impactful results supporting clinical and preclinical research obtained with high and low acoustic intensities regimes.
BibTeX
@inproceedings{conti2021editorial,
  author = {Allegra Conti and Hermes A. S. Kamimura and Anthony Novell and Andrea Duggento and Nicola Toschi},
  title = {{Editorial: Magnetic Resonance-Guided Focused Ultrasound: Physical Principles and Biomedical Applications}},
  booktitle = {Frontiers in Physics},
  year = {2021},
  doi = {10.3389/fphy.2021.683899},
}

Loading related content...

Figure